Karyotypic evolution: cytogenetics follow-up study in childhood acute lymphoblastic leukemia. 2003

Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran 14155, IR.Iran mehdipor@sina.tums.ac.ir

Forty seven children affected with acute lymphoblastic leukemia (ALL) were cytogenetically investigated at diagnosis and all through different stages of the disease (remission and relapse). A clonal karyotypic abnormality was found in 32% at diagnosis (mainly comprised of cALLa+). A hyperdiploid mode with chromosome counts ranging from 47-58, was found to be most prominent among cALLa+ patients. The most common numerical aberrations were gain of chromosomes 2, 5, and 21. The structural aberrations at diagnosis were found to be del(9)(p22), inv(9)(p11q13) and del(19)(p12). None of the children showed ph+ chromosome. A good prognosis was found in cALLa+ children with an abnormal karyotype at diagnosis and of these children, those who showed karyotypic instability, had a significantly longer first remission time. The karyotypic evolution through remission(s) and relapse(s) revealed the occurrence of structural alterations, including changes in chromosomes 3, 6, 9, 21 and 22. However, irrespective of the karyotypic clonal nature at diagnosis, chromosome 9 was the most commonly involved chromosome through the course of disease.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
January 1990, Haematology and blood transfusion,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
January 2015, Clinical Medicine Insights. Oncology,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
January 1987, Haematology and blood transfusion,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
May 2006, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
September 1994, Cancer genetics and cytogenetics,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
August 2003, The New England journal of medicine,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
September 2006, Pediatric hematology and oncology,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
February 2009, Cancer genetics and cytogenetics,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
January 1991, Nouvelle revue francaise d'hematologie,
Parvin Mehdipour, and Reza Mirfakhraie, and Mohammad Jahani, and Abdol-Reza Mehdipour
July 2015, Nature immunology,
Copied contents to your clipboard!